On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

Historically, providers would need to log into separate portals or support different workflows for each CGM manufacturer to review the data from their patients. Additionally, it was cumbersome to ...

Tidepool and Abbott’s new data integration will simplify data sharing by automating data upload to Tidepool for patients ...

Abbott today announced that its FreeStyle Libre 2 and 3 systems can now be worn during common imaging procedures, such as X-rays, CT scans and MRIs*. The U.S. Food and Drug Administration (FDA) ...

Abbott announced today that the FDA said users can wear the FreeStyle Libre 2 and 3 CGMs during common imaging procedures.

general manager of Abbott's UK and Ireland diabetes care business. In clinical trials, use of the Freestyle Libre CGM range has been shown to improve blood glucose control, reducing hypoglycaemic ...

The US Food and Drug Administration has okayed removal of the contraindication for use during CT and MRI under certain ...

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

Diabetes Care Sales ... exceeding $1.6 billion in sales. Abbott Laboratories (NYSE:ABT) entered into a global partnership with Medtronic to connect its FreeStyle Libre CGM sensor with automated ...

Abbott’s Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose monitoring system, FreeStyle Libre. In a relatively short span ...